Semi-Quantitative Enzyme-Linked Immunosorbent Assay
New York DOH Approval Status
Serum separator tube.
Separate serum from cells ASAP or within 2 hours of collection. Transfer 1 mL serum to an ARUP Standard Transport Tube. (Min: 0.15 mL) Parallel testing is preferred and convalescent specimens must be received within 30 days from receipt of the acute specimens. Mark specimens plainly as "acute" or "convalescent."
Contaminated, heat-inactivated, hemolyzed, or severely lipemic specimens.
After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year (avoid repeated freeze/thaw cycles)
|Effective February 20, 2018|
|0.94 IV or less||Negative - No significant level of detectable B. pertussis IgG antibody.|
|0.95-1.04 IV||Equivocal Repeat testing in 10-14 days may be helpful.|
|1.05 IV or greater||Positive IgG antibody to B. pertussis detected, which may indicate a current or recent exposure/immunization to B. pertussis.|
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Laboratory Developed Test (LDT)
|Component Test Code*||Component Chart Name||LOINC|
|2001782||B. pertussis Ab, IgG by ELISA||42330-1|
- B. pertussis IgG ELISA
- Pertussis Antibody
- Pertussis IgG Ab ELISA